These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 10487292)

  • 1. Pleomorphic basal cell carcinoma of the eyelid with true ductular differentiation.
    Jakobiec FA; Zakka FR; Townsend DJ
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):451-4. PubMed ID: 22037988
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibroepithelioma of pinkus with tumor giant cells.
    Val-Bernal JF; Gómez-Ortega JM; Fernández-Llaca H; Gómez-Román JJ
    Am J Dermatopathol; 2002 Aug; 24(4):336-9. PubMed ID: 12142615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
    Mateoiu C; Pirici A; Bogdan F
    Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
    Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
    J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
    Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical characterization of pleomorphic giant cells in basal cell carcinoma.
    Cutlan RT; Maluf HM
    J Cutan Pathol; 1999 Aug; 26(7):353-6. PubMed ID: 10487292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal cell carcinoma with tumor epithelial and stromal giant cells: a variant of pleomorphic basal cell carcinoma.
    Meehan SA; Egbert BM; Rouse RV
    Am J Dermatopathol; 1999 Oct; 21(5):473-8. PubMed ID: 10535579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumors of the pancreas with osteoclast-like and pleomorphic giant cells: an immunohistochemical and ploidy study.
    Deckard-Janatpour K; Kragel S; Teplitz RL; Min BH; Gumerlock PH; Frey CF; Ruebner BH
    Arch Pathol Lab Med; 1998 Mar; 122(3):266-72. PubMed ID: 9823867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical giant trichoblastoma: An unusual presentation.
    Nguyen LV; Masouminia M; Choy JO; Peng SK; Ji P; French SW
    Exp Mol Pathol; 2017 Feb; 102(1):22-24. PubMed ID: 27836679
    [No Abstract]   [Full Text] [Related]  

  • 10. Giant basal cell carcinoma. Report of two cases and review of the literature.
    Sahl WJ; Snow SN; Levine NS
    J Am Acad Dermatol; 1994 May; 30(5 Pt 2):856-9. PubMed ID: 8169262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleomorphic lobular carcinoma of the breast with osteoclast-like giant cells: a case report and review of the literature.
    Peña-Jaimes L; González-García I; Reguero-Callejas ME; Pinilla-Pagnon I; Pérez-Mies B; Albarrán-Artahona V; Martínez-Jañez N; Rosa-Rosa JM; Palacios J
    Diagn Pathol; 2018 Aug; 13(1):62. PubMed ID: 30153845
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.